by Iga VonGeyso | May 23, 2024 | Article
AbbVie’s Humira (adalimumab) has been one of the world’s highest grossing drugs in history 1 and biosimilar utilization was uncertain when Humira’s patent expired in 2023. Surprising even AbbVie, Humira retained stronger retention than 2023 forecasts 2. However, that...
by Iga VonGeyso | Apr 2, 2024 | Article
Prescription discount cards have existed since the 1990s but gained massive popularity following GoodRx’s launch in 2011. From PBM programs like Express Scripts’ Inside Rx, online giants like Amazon’s Rx Savings, to retail pharmacies like Walgreen’s Prescription...
by Iga VonGeyso | Feb 5, 2024 | Article
Artificial Intelligence (AI) has existed since the 1950s1 but exploded in recent popularity as generative/conversational AI enables users to create written and visual content, flooding the educational and creative worlds with new capabilities but also placing the...
by Iga VonGeyso | Dec 18, 2023 | Article
The Inflation Reduction Act of 2022 triggered a flurry of Congressional bills to curb rising drug prices. The Congressional Budget Office (CBO) noted that the increased utilization of generics was not enough to offset the rising prices of brand drugs in recent years...
by Iga VonGeyso | Dec 18, 2023 | Article
Ozempic, Mounjaro, and Wegovy are some of the explosively popular GLP-1 drugs making headlines in 2023. GLP-1 stands for Glucagon-like Peptide-1, a hormone released during eating that prompts insulin production and increases feelings of satiety. GLP-1 Receptor...